Statistics
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
| Views | |
|---|---|
| A ... | 841 |
Total Visits Per Month
| November 2021 | December 2021 | January 2022 | February 2022 | March 2022 | April 2022 | May 2022 | |
|---|---|---|---|---|---|---|---|
| A ... | 34 | 15 | 21 | 21 | 8 | 11 | 0 |
File Visits
| Views | |
|---|---|
| 29FL5e9GFDkgQ.pdf | 309 |